Download PDFPDF

Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Prescribing need is multifactorial

    Dear Editor

    While I applaud the aim of Ward, Noyce and St Leger [1] to promote equality of prescribing I fear that their method is overly simplistic. While I have reservations about how they chose to measure some variables, my main objection is that they have only examined relationships between two variables at a time and have failed to examine correlations between explanatory variables. Such an approach can lead to...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Ethnicity and Prescribing

    Dear Editor

    My understanding, confirmed by brief review of data on the ONS website, is that the South Asian population in the UK has a younger age distribution than the white population. In this case, would an indicator based on those aged over 35 need further adjustment for the age distribution beyond 35 in order to examine prescribing? Is it possible that we are seeing an age effect in the negative correlation...

    Show More
    Conflict of Interest:
    None declared.